Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

Novavax. United States. Announced Date 24/09/2013. Closed Date 27/09/2013. Deal value: $87m. Registered direct offering of common stock. Industry: Novavax is a biotechnology company specializing in the development of vaccines for infectious diseases.

Back to Search Contact Business